Evaluation of beta-blockers for the treatment of asthma and chronic obstructive pulmonary disease
Beta-blockers are avoided in asthma and chronic obstructive pulmonary disease (COPD) due to the potential risk of drug induced bronchospasm. Despite these concerns, beta-adrenoceptor antagonism has recently been associated with potential therapeutics benefits in asthma. Furthermore the use of beta-b...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Dundee
2014
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.600773 |